TLRY Logo

Tilray Brands, Inc. (TLRY) 

NASDAQ
Market Cap
$1.4B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
196 of 776
Rank in Industry
7 of 47

Largest Insider Buys in Sector

TLRY Stock Price History Chart

TLRY Stock Performance

About Tilray Brands, Inc.

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and …

Insider Activity of Tilray Brands, Inc.

Over the last 12 months, insiders at Tilray Brands, Inc. have bought $183,210 and sold $0 worth of Tilray Brands, Inc. stock.

On average, over the past 5 years, insiders at Tilray Brands, Inc. have bought $183,210 and sold $48.55M worth of stock each year.

Highest buying activity among insiders over the last 12 months: SIMON IRWIN D (President and CEO) — $302,868. Gendel Mitchell (Global General Counsel) — $73,062. FALTISCHEK DENISE M (Chief Strategy Officer) — $41,000.

The last purchase of 10,000 shares for transaction amount of $20,500 was made by FALTISCHEK DENISE M (Chief Strategy Officer) on 2024‑01‑17.

List of Insider Buy and Sell Transactions, Tilray Brands, Inc.

2024-01-17PurchaseChief Strategy Officer
10,000
0.0013%
$2.05$20,500-12.41%
2024-01-16PurchaseGlobal General Counsel
7,200
0.0009%
$1.98$14,256-13.25%
2024-01-12PurchasePresident and CEO
53,700
0.0073%
$1.88$100,956-3.74%
2024-01-12PurchaseGlobal General Counsel
5,400
0.0007%
$1.87$10,098-3.74%
2024-01-12PurchaseChief Financial Officer
20,000
0.0027%
$1.87$37,400-3.74%
2022-11-07Saledirector
350,000
0.0575%
$3.78$1.32M-32.98%
2022-10-05Saledirector
350,000
0.0559%
$2.91$1.02M
2022-09-06Sale
350,000
0.0582%
$3.22$1.13M-13.41%
2022-08-05Sale
350,000
0.061%
$3.91$1.37M-27.69%
2022-07-05Sale
350,000
0.058%
$3.09$1.08M-7.10%
2021-08-05Sale
600,000
0.1334%
$14.46$8.68M-53.59%
2021-08-04Sale
600,000
0.1365%
$14.27$8.56M-51.36%
2021-07-16Sale
600,000
0.1347%
$14.04$8.42M-47.88%
2021-07-15Sale
600,000
0.136%
$14.67$8.8M-49.55%
2021-06-18Sale
800,000
0.1809%
$17.19$13.75M-51.86%
2021-06-17Sale
800,000
0.1791%
$17.58$14.06M-53.41%
2021-06-03Sale
47,652
0.0106%
$19.64$935,885-51.62%
2021-05-12Sale
178,000
0.0407%
$14.82$2.64M-27.74%
2020-12-16Saledirector
4,400
0.0015%
$10.00$44,000+57.13%
2020-11-06SalePresident and CEO
800,000
0.2825%
$9.88$7.91M+52.75%

Insider Historical Profitability

141.09%
SIMON IRWIN DPresident and CEO
2033058
0.2251%
$1.5510
FALTISCHEK DENISE MChief Strategy Officer
293269
0.0325%
$1.5510
Gendel MitchellGlobal General Counsel
195796
0.0217%
$1.5520
Merton Carl AChief Financial Officer
20000
0.0022%
$1.5511
Kennedy Brendandirector
6224196
0.6891%
$1.55133+141.09%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.